Bill Wexler's Profits of DOOM Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Bill Wexler's Profits of DOOM

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Bill Wexler who wrote (4565)	3/2/1999 2:16:00 AM
From: Mark L.	Read Replies (1) of 4634

Since I know you are fond of ZONA, here's another thought: MacroChem (MCHM). Twenty employees, $240 million market cap, no Schering-Plough (or anyone else) to market their ED drug, a long history of management not delivering on projections, a too easily-grasped concept, and rabid, misinformed evangelists on their Yahoo! board. It's had a nice run-up the last couple of days on mini-orders (only a couple of blocks). I do not recommend shorting it in the next few days, just to be absolutely sure they're not about to sign a strategic partnership and to give the momentum players a chance to exhaust themselves. Obviously, before shorting it, you have to make yourself comfortable with the limitations of trans-dermal therapy. Disclaimer: I have a decent-sized short position that I'll probably be adding to.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next